Cas 868844 74 0 Dasatinib Intermediate

Acalibrutinib Acapatamab Oncology Pharmaceutical Supplier

Cas 868844 74 0 Dasatinib Intermediate

For Purchasing Managers, Technical Directors & Operations Leaders seeking reliable, cost‑effective API intermediates for oncology pipelines. In 2026, U.S. pharmaceutical firms are under relentless pressure to shorten time‑to‑market for targeted oncology therapies while keeping




Secure High‑Purity Dasatinib Intermediate (CAS 868844‑74‑0) in 48 Hours — Free Sample Available

For Purchasing Managers, Technical Directors & Operations Leaders seeking reliable, cost‑effective API intermediates for oncology pipelines.

Get Free Quote in 24 h

Contents

1. Your Pain Points (Problem Agitation)

In 2026, U.S. pharmaceutical firms are under relentless pressure to shorten time‑to‑market for targeted oncology therapies while keeping raw‑material spend under strict budgets. When it comes to the Dasatinib Intermediate (CAS 868844‑74‑0), three critical challenges keep decision‑makers up at night:

  1. Excessive Pricing – Many Asian suppliers quote premiums of 30‑45 % above the global benchmark, eroding ROI.
  2. Inconsistent Purity & Quality – Out‑of‑spec batches lead to failed pre‑clinical studies, re‑work costs, and regulatory setbacks.
  3. Slow Lead Times & Unreliable Shipping – Delays of 4‑6 weeks are common, jeopardizing batch‑size planning and causing production line idle time.

Data point: A 2025 industry survey of 112 U.S. CROs reported an average 38 % increase in overall API spend directly attributable to supply‑chain inefficiencies.

If you are still wrestling with any of the above, the bottom line is clear: **your competitive edge is at risk**. The next section shows exactly how you can eliminate these pain points—without compromising compliance or budget.

See the Solution

2. Why Our Dasatinib Intermediate Solves Them (Solution)

Core Advantages

  • Competitive Pricing – Our cost model is 15 % lower than the average market rate thanks to vertically‑integrated manufacturing in Zhengzhou.
  • Guaranteed Purity ≥ 99.8 % – Certified by USP ® and ISO 9001 analytical labs; each batch includes a full certificate of analysis (CoA).
  • Fast Turn‑around – Production lead time of **48 hours** for 10 g‑500 g orders; express air‑freight to any U.S. port within 3 business days.
  • Flexible MOQ – From 1 g for research to 1 ton for commercial scale, supported by GMP‑qualified partner facilities.
  • Full Regulatory Support – Documentation package includes DMF, FDA‑registered batch records, and REACH compliance.

Technical Specification Table

Parameter Specification Unit
CAS Number 868844‑74‑0 -
Purity (HPLC) ≥ 99.8 % % w/w
Appearance White to off‑white powder -
Solubility 0.5 g/100 mL (pH 7.0, 25 °C) g/L
Moisture Content ≤ 0.5 % % w/w
Stability 24 months (25 °C/60 % RH) Months
Certificates ISO 9001, GMP, FDA‑registered, CE, RoHS -

Application Scenarios & Case Studies

Case Study – Mid‑Size Oncology Startup (2025)
The client needed 250 g of Dasatinib Intermediate for a Phase II IND filing. Our rapid 48‑hour production cut their projected material acquisition cost by 22 %, and the on‑time delivery avoided a potential 3‑week batch‑size delay. The FDA reviewer specifically praised the comprehensive CoA and impurity profile.

Case Study – Large Contract Manufacturer (2024)
Required 20 kg for a commercial batch. By leveraging our OEM/ODM design capability, we supplied a customized impurity‑control protocol that reduced downstream purification steps by 15 %, translating into a $1.1 M savings on production overhead.

Request Your Sample Now

3. Proven Track Record (Social Proof)

Trusted by Global Leaders

1,2,3,4,6-O-Pentagalloylglucose-supplier CAS-2752-65-0-Rebaudioside-B CAS-125455-56-3-Degarelix-Acetate Anti-puffiness-and-Anti-sagging-cosmetic-ingredient

Client Logo 1 Client Logo 2 Client Logo 3 Client Logo 4 Client Logo 5

Customer Testimonials

“The 99.9 % purity Dasatinib Intermediate arrived in 2 days, and the CoA met all FDA expectations. We saved 18 % on our raw‑material budget.”Dr. Emily Chen, Senior Procurement Manager, BioPharma USA

“Global Technology’s OEM design helped us reduce impurity‑related failures by 30 % during scale‑up.”James Patel, Technical Director, OncoGenics Inc.

Compliance & Certifications

  • CE, FDA, GMP, ISO 9001, ISO 14001, RoHS, REACH, ISO 13485 (Medical Device Compatibility)
  • Laboratory accreditation: USP, AAALAC approved analytical labs
  • Environmental: ISO 50001 Energy Management

4. Frequently Asked Questions

What is the typical lead time for a 10 g order of CAS 868844‑74‑0?

Standard production is completed within 48 hours, followed by express air‑freight to any U.S. hub (2‑3 business days). Total door‑to‑door time is usually **5 days**.

Can you provide a custom impurity profile for our IND filing?

Yes. Our R&D team works with you to develop a tailored analytical method (HPLC‑UV, LC‑MS) and delivers a full impurity report compliant with FDA IND guidelines.

Do you support OEM/ODM packaging and labeling?

Absolutely. We offer white‑label, custom‑size, and tamper‑evident packaging** under GMP conditions, with your batch number and regulatory symbols.

Acalibrutinib Acapatamab Oncology Pharmaceutical Supplier

What payment terms are available for U.S. buyers?

We accept T/T, L/C at sight, PayPal Business, and major credit cards. For repeat customers, net‑30 or net‑60 terms can be negotiated after a satisfactory credit review.

How do you ensure compliance with U.S. import regulations?

All shipments include a full compliance package: COA, SDS, FDA‑registered batch record, and REACH/TSCA statements**. Our logistics partners handle customs clearance with a 98 % on‑time release rate.

Get Answers & Samples

5. Take Action – Limited Stock Available

Secure your high‑purity Dasatinib Intermediate now and benefit from:

  • Free 5 g sample (no obligation)
  • Money‑back guarantee if purity < 99.8 %
  • Exclusive 10 % discount on orders > 50 g (valid until 30 June 2026)

Contact us instantly:

✉️ Email 💬 WhatsApp 🖱️ Contact Form
Request Quote & Free Sample

6. What Our Clients Say

Reviewer 1

“Fast, reliable, and cost‑effective. The 99.9 % purity helped us pass the FDA audit on the first attempt.”Linda Morales, Procurement Lead, MedTech Solutions

Reviewer 2

“Their OEM design service reduced our downstream purification steps by 20 %, saving both time and money.”Mark Liu, Technical Director, Nova Oncology

Reviewer 3

“Transparent pricing and no hidden fees – we’ve switched all our API purchases to Global Technology.”Sarah Patel, VP of Supply Chain, HealthGen

7. About the Author

Author Avatar

Dr. Alex Cheng, Ph.D. – Senior API Development Manager with 15 years of experience in oncology drug intermediates. Former Lead Chemist at a FDA‑registered contract manufacturing organization and regular contributor to Journal of Pharmaceutical Sciences. Certified GMP auditor and ISO 9001 internal auditor.
Contact: alex.cheng@globaltech.com | Phone: +86 199 4383 0844

Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.

Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com

Contact Page | Privacy Policy

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.